Co-Diagnostics, Inc. (CODX) Gross Margin
- Gross margin · 12 months: Value 43.48%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 43.48% | Gross profit / revenue. Period ending 2026-06-30. $313.63K ÷ $721.39K × 100 ≈ 43.48% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 313.63K USD | Gross Profit |
| Revenue | 721.39K USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $313.63K | $721.39K | (m) | 43.48% |
| 2026-03-31 | $323.61K | $718.17K | (m) | 45.06% |
| 2025-12-31 | $400.11K | $622.49K | (m) | 64.28% |
| 2025-09-30 | $172.84K | $507.89K | (m) | 34.03% |
| 2025-06-30 | $397.49K | $1.00M | (m) | 39.60% |
| 2025-03-31 | $2.71M | $3.50M | (m) | 77.52% |
| 2024-12-31 | $2.92M | $3.92M | (m) | 74.48% |
| 2024-09-30 | $3.61M | $7.32M | (m) | 49.30% |
| 2024-06-30 | $5.47M | $9.14M | (m) | 59.83% |
| 2024-03-31 | $2.76M | $6.68M | (m) | 41.34% |
| 2023-12-31 | $2.63M | $6.81M | (m) | 38.57% |
| 2023-09-30 | $2.93M | $4.66M | (m) | 62.80% |
| 2023-06-30 | $5.05M | $7.30M | (m) | 69.23% |
| 2023-03-31 | $9.42M | $12.12M | (m) | 77.71% |
| 2022-12-31 | $28.74M | $34.22M | (m) | 83.98% |
| 2022-09-30 | $45.77M | $53.22M | (m) | 86.00% |
| 2022-06-30 | $68.23M | $78.22M | (m) | 87.22% |
| 2022-03-31 | $88.98M | $100.56M | (m) | 88.48% |
| 2021-12-31 | $86.31M | $97.89M | (m) | 88.18% |
| 2021-09-30 | $91.23M | $104.63M | (m) | 87.19% |
| 2021-06-30 | $80.44M | $96.35M | (m) | 83.49% |
| 2021-03-31 | $73.65M | $93.03M | (m) | 79.17% |
| 2020-12-31 | $57.96M | $74.55M | (m) | 77.75% |
| 2020-09-30 | $35.18M | $47.52M | (m) | 74.05% |
| 2020-06-30 | $16.84M | $25.74M | (m) | 65.42% |
| 2020-03-31 | $1.17M | $1.76M | (m) | 66.27% |
| 2019-12-31 | $102.54K | $214.97K | (m) | 47.70% |
| 2019-09-30 | $48.21K | $117.23K | (m) | 41.13% |
| 2019-06-30 | $36.84K | $85.49K | (m) | 43.09% |
| 2019-03-31 | $23.77K | $33.62K | (m) | 70.72% |
| 2018-12-31 | $30.52K | $39.91K | (m) | 76.47% |
| 2018-09-30 | $31.69K | (m) | (m) | (m) |
| 2018-06-30 | $24.59K | (m) | (m) | (m) |
| 2018-03-31 | $17.06K | (m) | (m) | (m) |
| 2017-12-31 | $7.36K | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |